Clinical Trial Update: PersonaLized neoAdjuvant Strategy ER Positive and HER2 Negative Breast Cancer TO Increase BCS Rate [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update describing a personalized neoadjuvant strategy for ER-positive, HER2-negative breast cancer to raise breast-conserving surgery rat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Seoul National University Hospital | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING